Bio-Rad Laboratories, Inc.

The current price of BIO is 290.86 USD — it has decreased by 0.65% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bio-Rad Laboratories, Inc. stocks are traded under the ticker BIO.

Bio-Rad Laboratories, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Bio-Rad Laboratories, Inc. has a max estimate of 474.00 USD and a min estimate of 350.00 USD.

BIO earnings for the last quarter are 2.33 USD whereas the estimation was 2.78 USD which accounts for −16.25% surprise. Estimated earnings for the next quarter are 2.82 USD. See more details about Bio-Rad Laboratories, Inc. earnings.

Yes, you can track Bio-Rad Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.

BIO stock has fallen by 11.94% compared to the previous week, the month change is a 12.88% fall, over the last year Bio-Rad Laboratories, Inc. has showed a 39.60% decrease.

Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Rad Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.

BIO reached its all-time high on Sep 2, 2021 with the price of 832.70 USD, and its all-time low was 0.87 USD and was reached on Aug 19, 1982.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has ‪8.03 K‬ employees. See our rating of the largest employees — is Bio-Rad Laboratories, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio-Rad Laboratories, Inc. EBITDA is ‪589.27 M‬ USD, and current EBITDA margin is 21.57%. See more stats in Bio-Rad Laboratories, Inc. financial statements.